知镜 Cognispect · 医学文献与研究工作台

Association Between Thyroid Function and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Case-Control Study.

Orabi IA, Elhadidy AA, Amro OAEA, Attia AA, Abdelkader AA, Mohamed ES, Alsayyad MMAA, Sakr Elfors AF, Abdelmalak MWM, Hegab SMEA, Rashwan TH, Ismail HAM, Hegazy HA, Mashaal SA.
La Clinica terapeutica · 2026-09-01 · PMID 42664128

文献摘要

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is highly prevalent among patients with type 2 diabetes mellitus (T2DM) and is closely linked to metabolic disturbances such as insulin resistance and dyslipidemia. Thyroid hormones play a critical role in regulating hepatic lipid metabolism and energy homeostasis; however, their relationship with MAFLD in diabetic populations remains incompletely defined. Methods In this case-control study, 150 patients with T2DM were enrolled, including 75 patients with MAFLD and 75 without MAFLD. Hepatic steatosis was confirmed using transient elastography with controlled attenuation parameter (CAP). Serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) were measured using chemiluminescent immunoassays. Clinical, anthropometric, and biochemical parameters were assessed. Multivariate logistic regression analysis was performed to identify independent predictors of MAFLD. Results Patients with MAFLD had significantly lower FT3 levels and higher TSH levels compared with diabetic controls without MAFLD (p = 0.016 and p Conclusions Elevated TSH levels are independently associated with MAFLD in patients with T2DM, suggesting a link between thyroid function and hepatic steatosis beyond traditional metabolic risk factors. These findings highlight the potential role of thyroid function, particularly TSH, in the metabolic risk stratification of patients with diabetes and warrant further investigation into thyroid-liver interactions.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。